1. GBD 2016 Diarrhoeal Disease Collaborators. Estimates of the global,
regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195
countries: a systematic analysis for the Global Burden of Disease Study 2016.
Lancet Infect Dis 2018; 18:1211.
2. Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of
America Clinical Practice Guidelines for the Diagnosis and Management of
Infectious Diarrhea. Clin Infect Dis 2017; 65:e45.
3. Riddle MS, DuPont HL, Connor BA. ACG Clinical Guideline: Diagnosis,
Treatment, and Prevention of Acute Diarrheal Infections in Adults. Am J
Gastroenterol 2016; 111:602.
4. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the
management of infectious diarrhea. Clin Infect Dis 2001; 32:331.
5. Dryden MS, Gabb RJ, Wright SK. Empirical treatment of severe acute
community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis 1996;
22:1019.
6. Wanke CA. Small intestinal infections. Curr Opin Gastroenterol 1994; 10:59.
7. Thielman NM, Guerrant RL. Clinical practice. Acute infectious diarrhea. N
Engl J Med 2004; 350:38.
8. Koplan JP, Fineberg HV, Ferraro MJ, Rosenberg ML. Value of stool cultures.
Lancet 1980; 2:413.
9. Bresee JS, Marcus R, Venezia RA, et al. The etiology of severe acute
gastroenteritis among adults visiting emergency departments in the United
States. J Infect Dis 2012; 205:1374.
10. Rohner P, Pittet D, Pepey B, et al. Etiological agents of infectious diarrhea:
implications for requests for microbial culture. J Clin Microbiol 1997;
35:1427.
11. Savola KL, Baron EJ, Tompkins LS, Passaro DJ. Fecal leukocyte stain has
diagnostic value for outpatients but not inpatients. J Clin Microbiol 2001;
39:266.
12. Jean S, Yarbrough ML, Anderson NW, Burnham CA. Culture of Rectal Swab
Specimens for Enteric Bacterial Pathogens Decreases Time to Test Result
While Preserving Assay Sensitivity Compared to Bulk Fecal Specimens. J
Clin Microbiol 2019; 57.
13. Kotar T, Pirš M, Steyer A, et al. Evaluation of rectal swab use for the
determination of enteric pathogens: a prospective study of diarrhoea in adults.
Clin Microbiol Infect 2019; 25:733.
14. Kotton CN, Lankowski AJ, Hohmann EL. Comparison of rectal swabs with
fecal cultures for detection of Salmonella typhimurium in adult volunteers.
Diagn Microbiol Infect Dis 2006; 56:123.
15. Guerrant RL, Shields DS, Thorson SM, et al. Evaluation and diagnosis of
acute infectious diarrhea. Am J Med 1985; 78:91.
16. DeGirolami PC, Ezratty CR, Desai G, et al. Diagnosis of intestinal
microsporidiosis by examination of stool and duodenal aspirate with Weber's
modified trichrome and Uvitex 2B strains. J Clin Microbiol 1995; 33:805.
17. Hart AS, Ridinger MT, Soundarajan R, et al. Novel organism associated with
chronic diarrhoea in AIDS. Lancet 1990; 335:169.
18. Axelrad JE, Freedberg DE, Whittier S, et al. Impact of Gastrointestinal Panel
Implementation on Health Care Utilization and Outcomes. J Clin Microbiol
2019; 57.
19. Binnicker MJ. Multiplex Molecular Panels for Diagnosis of Gastrointestinal
Infection: Performance, Result Interpretation, and Cost-Effectiveness. J Clin
Microbiol 2015; 53:3723.
20. Chitkara YK, McCasland KA, Kenefic L. Development and implementation of
cost-effective guidelines in the laboratory investigation of diarrhea in a
community hospital. Arch Intern Med 1996; 156:1445.
21. Huicho L, Sanchez D, Contreras M, et al. Occult blood and fecal leukocytes as
screening tests in childhood infectious diarrhea: an old problem revisited.
Pediatr Infect Dis J 1993; 12:474.
22. Herbert ME. Medical myth: Measuring white blood cells in the stools is useful
in the management of acute diarrhea. West J Med 2000; 172:414.
23. Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and
specific marker in identifying intestinal inflammation. Am J Gastroenterol
2003; 98:1309.
24. Siegel DL, Edelstein PH, Nachamkin I. Inappropriate testing for diarrheal
diseases in the hospital. JAMA 1990; 263:979.
25. Aisenberg GM, Grimes RM. Computed tomography in patients with
abdominal pain and diarrhoea: does the benefit outweigh the drawbacks?
Intern Med J 2013; 43:1141.
26. Guerri S, Danti G, Frezzetti G, et al. Clostridium difficile colitis: CT findings
and differential diagnosis. Radiol Med 2019; 124:1185.
27. Avery ME, Snyder JD. Oral therapy for acute diarrhea. The underused simple
solution. N Engl J Med 1990; 323:891.
28. Carpenter CC, Greenough WB, Pierce NF. Oral-rehydration therapy--the role
of polymeric substrates. N Engl J Med 1988; 319:1346.
29. Santosham M, Burns B, Nadkarni V, et al. Oral rehydration therapy for acute
diarrhea in ambulatory children in the United States: a double-blind
comparison of four different solutions. Pediatrics 1985; 76:159.
30. Duggan C, Santosham M, Glass RI. The management of acute diarrhea in
children: oral rehydration, maintenance, and nutritional therapy. Centers for
Disease Control and Prevention. MMWR Recomm Rep 1992; 41:1.
31. de Zoysa I, Kirkwood B, Feachem R, Lindsay-Smith E. Preparation of sugar-
salt solutions. Trans R Soc Trop Med Hyg 1984; 78:260.
32. Wiström J, Jertborn M, Ekwall E, et al. Empiric treatment of acute diarrheal
disease with norfloxacin. A randomized, placebo-controlled study. Swedish
Study Group. Ann Intern Med 1992; 117:202.
33. Bennish ML, Salam MA, Haider R, Barza M. Therapy for shigellosis. II.
Randomized, double-blind comparison of ciprofloxacin and ampicillin. J
Infect Dis 1990; 162:711.
34. Khan WA, Seas C, Dhar U, et al. Treatment of shigellosis: V. Comparison of
azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial.
Ann Intern Med 1997; 126:697.
35. Wong CS, Jelacic S, Habeeb RL, et al. The risk of the hemolytic-uremic
syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N
Engl J Med 2000; 342:1930.
36. Mattila L, Peltola H, Siitonen A, et al. Short-term treatment of traveler's
diarrhea with norfloxacin: a double-blind, placebo-controlled study during two
seasons. Clin Infect Dis 1993; 17:779.
37. Salam I, Katelaris P, Leigh-Smith S, Farthing MJ. Randomised trial of single-
dose ciprofloxacin for travellers' diarrhoea. Lancet 1994; 344:1537.
38. Taylor DN, Sanchez JL, Candler W, et al. Treatment of travelers' diarrhea:
ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-
controlled, randomized trial. Ann Intern Med 1991; 114:731.
39. Pichler HE, Diridl G, Stickler K, Wolf D. Clinical efficacy of ciprofloxacin
compared with placebo in bacterial diarrhea. Am J Med 1987; 82:329.
40. Sirinavin S, Garner P. Antibiotics for treating salmonella gut infections.
Cochrane Database Syst Rev 2000; :CD001167.
41. Prince Christopher R H, David KV, John SM, Sankarapandian V. Antibiotic
therapy for Shigella dysentery. Cochrane Database Syst Rev 2010;
:CD006784.
42. Ternhag A, Asikainen T, Giesecke J, Ekdahl K. A meta-analysis on the effects
of antibiotic treatment on duration of symptoms caused by infection with
Campylobacter species. Clin Infect Dis 2007; 44:696.
43. Petruccelli BP, Murphy GS, Sanchez JL, et al. Treatment of traveler's diarrhea
with ciprofloxacin and loperamide. J Infect Dis 1992; 165:557.
44. Murphy GS, Bodhidatta L, Echeverria P, et al. Ciprofloxacin and loperamide
in the treatment of bacillary dysentery. Ann Intern Med 1993; 118:582.
45. Riddle MS, Arnold S, Tribble DR. Effect of adjunctive loperamide in
combination with antibiotics on treatment outcomes in traveler's diarrhea: a
systematic review and meta-analysis. Clin Infect Dis 2008; 47:1007.
46. DuPont HL, Hornick RB. Adverse effect of lomotil therapy in shigellosis.
JAMA 1973; 226:1525.
47. Steffen R. Worldwide efficacy of bismuth subsalicylate in the treatment of
travelers' diarrhea. Rev Infect Dis 1990; 12 Suppl 1:S80.
48. Graham DY, Estes MK, Gentry LO. Double-blind comparison of bismuth
subsalicylate and placebo in the prevention and treatment of enterotoxigenic
Escherichia coli-induced diarrhea in volunteers. Gastroenterology 1983;
85:1017.
49. DuPont HL, Sullivan P, Pickering LK, et al. Symptomatic treatment of
diarrhea with bismuth subsalicylate among students attending a Mexican
university. Gastroenterology 1977; 73:715.
50. DuPont HL, Flores Sanchez J, Ericsson CD, et al. Comparative efficacy of
loperamide hydrochloride and bismuth subsalicylate in the management of
acute diarrhea. Am J Med 1990; 88:15S.
51. Johnson PC, Ericsson CD, DuPont HL, et al. Comparison of loperamide with
bismuth subsalicylate for the treatment of acute travelers' diarrhea. JAMA
1986; 255:757.
52. Salazar-Lindo E, Santisteban-Ponce J, Chea-Woo E, Gutierrez M.
Racecadotril in the treatment of acute watery diarrhea in children. N Engl J
Med 2000; 343:463.
53. Gallelli L, Colosimo M, Tolotta GA, et al. Prospective randomized double-
blind trial of racecadotril compared with loperamide in elderly people with
gastroenteritis living in nursing homes. Eur J Clin Pharmacol 2010; 66:137.
54. Prado D, Global Adult Racecadotril Study Group. A multinational comparison
of racecadotril and loperamide in the treatment of acute watery diarrhoea in
adults. Scand J Gastroenterol 2002; 37:656.
55. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute
infectious diarrhoea. Cochrane Database Syst Rev 2010; :CD003048.
56. Johnson, J. Y. M., McMullen, L. M., Hasselback, P., Louie, M., & Saunders, L. D. (2006). Travelers’ knowledge of prevention and treatment of travelers’ diarrhea. Journal of Travel Medicine, 13(6), 351–355.
57. Anidi I, Bazargan M, James FW. Knowledge and management of diarrhea among underserved minority parents/caregivers. Ambul Pediatr. 2002 May-Jun;2(3):201-6. doi: 10.1367/1539-4409(2002)002<0201:kamoda>2.0.co;2. PMID: 12014980.
58. Ross MH, Barron PM. Awareness of oral rehydration at well-baby clinics in Johannesburg. S Afr Med J. 1989 Nov 4;76(9):492-5. PMID: 2814729.
59. Moawed SA, Saeed AA. Knowledge and practices of mothers about infants' diarrheal episodes. Saudi Med J. 2000 Dec;21(12):1147-51. PMID: 11360088.
60. Ittiravivongs A, Masdoeki RS, Pattara-Arechachai J. Knowledge of diarrhea and socioeconomic factors in relation to the use of oral rehydration therapy in Samut Songkhram Province, Thailand. Southeast Asian J Trop Med Public Health. 2008 Jun;20(2):215-9. PMID: 2609211